Ifp Advisors, Inc Allovir, Inc. Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

A detailed history of Ifp Advisors, Inc transactions in Allovir, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 3,000 shares of ALVR stock, worth $1,350. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,000

Holding current value

$1,350

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Jul 30, 2024	BUY	$0.72 - $0.82 $2,160 - $2,460	3,000 New	3,000 $2,000
Q3 2022 Nov 08, 2022	BUY	$4.13 - $8.79 $28 - $61	7 New	7 $1,000

Others Institutions Holding ALVR

# of Institutions

Shares Held

44.6M

Call Options Held

14.9K

Put Options Held

200

Eco R1 Capital, LLC San Francisco, CA

11.3M
Shares

$5.08 Million
0.4% of portfolio
Octagon Capital Advisors LP New York, NY

11.2M
Shares

$5.04 Million
2.19% of portfolio
Siren, L.L.C. New York, NY

6.6M
Shares

$2.97 Million
0.27% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.28M
Shares

$1.48 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

2.65M
Shares

$1.19 Million
0.0% of portfolio

View Full List

About Allovir, Inc.

Ticker ALVR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,063,400
Market Cap $41.9M
Description
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...

More about ALVR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account